Andy Hahn
@onchahn
Genitourinary Medical Oncologist @MDAndersonNews. Opinions are my own.
ID: 807059132033314816
09-12-2016 03:07:46
1,1K Tweet
1,1K Followers
465 Following
Study from @sloan_kettering shows that ~20% of non-cc mRCC pts have germline mutations. Editorial in JAMA Oncology by Kathleen Cooney raises question whether all non-cc mRCC pts should be referred for germline testing? bit.ly/2ucJd20 Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO